209 results
Page 3 of 11
424B5
k02enegs
23 Apr 21
Prospectus supplement for primary offering
4:05pm
8-K
EX-1.1
1qydxyixx
22 Apr 21
NeuBase Therapeutics Announces Pricing of $40 Million Public Offering of Common Stock
9:33am
424B5
5x05hl9 tqa0mel7xppc
21 Apr 21
Prospectus supplement for primary offering
4:03pm
8-K
EX-10.1
m78gy8oeg65kp72sz
2 Dec 20
NeuBase Therapeutics Announces Appointment of Curt Bradshaw, Ph.D. as Chief Scientific Officer
9:57am
8-K
EX-10.1
242 ugpj66
11 Sep 20
Other Events
5:06pm
8-K
EX-10.1
awc e7tlic
28 Jul 20
NeuBase Therapeutics Strengthens Senior Management Team with Appointment of Industry Veteran William Mann, Ph.D., MBA as Chief Operating Officer
8:16am
424B5
bdx6 zmwtl5j2h
29 Apr 20
Prospectus supplement for primary offering
4:21pm
8-K
EX-1.1
9zdce6j4re9mze3 w16
29 Apr 20
NeuBase Therapeutics Announces Pricing of $31,500,000 Public Offering of Common Stock
12:00am
424B5
abt lmpy9
27 Apr 20
Prospectus supplement for primary offering
4:23pm
8-K/A
EX-99.2
qn2eik
26 Mar 20
Financial Statements and Exhibits
5:15pm